The Medicines Manufacturing Innovation Centre is being built at the heart of the emerging Advanced Manufacturing Innovation District Scotland.
The centre is a collaboration between CPI, University of Strathclyde, UK Research and Innovation, Scottish Enterprise and founding industry partners, AstraZeneca and GSK.
It will ensure the UK is a technology and innovation leader in pharmaceutical manufacturing, thereby boosting the competitiveness of both sectors. The initial focus will be on technology translation for small molecule drug manufacture.
With a collaborative innovation culture and state-of the art facilities, the new facility will enable industry, academia, healthcare providers and regulators to work collaboratively to address challenges and maximise technology opportunities within the medicines supply chain.
The new centre will be built alongside the National Manufacturing Institute Scotland, set to transform Scotland’s manufacturing skills and productivity. And it will also be located next to the Lightweight Manufacturing Centre at Westway Park, Scotland’s only facility for research and development of lightweight components.